Literature DB >> 35460022

Fluocinolone Acetonide Microemulsion in Combination with a Fractional Laser for the Treatment of Scalp Psoriasis.

Voraphol Vejjabhinanta1, Walaisiri Muangsiri1, Pornpen Werawatganone2.   

Abstract

This study introduces fluocinolone acetonide (FA) microemulsion in combination with ablative fractional lasering as a new effective treatment for scalp psoriasis. A pseudo-ternary phase diagram was constructed using the aqueous titration method. The suitable ratio of surfactant mixture (Smix):oil mixture (Omix):water was chosen from the microemulsion region of the diagram. FA was loaded into the selected ratio to prepare FA microemulsion. Ex vivo skin permeation study of the FA microemulsion with fractional laser assistance was performed to determine a proper ablative depth. A pilot clinical study was conducted to evaluate the efficacy of FA microemulsion and FA microemulsion combination with lasering at the optimum ablation depth. The selected microemulsion base contained (in wt%) 77% water, 20% Smix (Tween 80:ethanol, 2:1), 3% Omix (10% benzyl benzoate and 1% benzyl alcohol in bergamot oil), and 0.2% sodium carboxymethylcellulose. FA was loaded into this base at a concentration of 0.1%. The skin lasered at an ablation depth of 50 µm was conducted in the pilot clinical study. Scalp psoriasis responded well to the FA microemulsion. Psoriasis scalp severity index (PSSI) scores indicated that the FA microemulsion plus laser treatment provides higher efficacy than the FA microemulsion alone without any topical and systemic side effects. The efficacy of the treatments could be maintained for at least 1 week after treatment discontinuation. FA microemulsion was properly formulated and evaluated. The microemulsion demonstrating the greatest benefits was used in combination with ablative fractional lasering to treat scalp psoriasis.
© 2022. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.

Entities:  

Keywords:  Fluocinolone acetonide; Fractional laser; Microemulsion; Pilot study; Scalp psoriasis

Mesh:

Substances:

Year:  2022        PMID: 35460022     DOI: 10.1208/s12249-022-02249-1

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  20 in total

1.  CASTOR OIL AS A VEHICLE FOR PARENTERAL ADMINISTRATION OF STEROID HORMONES.

Authors:  C RIFFKIN; R HUBER; C H KEYSSER
Journal:  J Pharm Sci       Date:  1964-08       Impact factor: 3.534

Review 2.  Clinical Pharmacology of Citrus bergamia: A Systematic Review.

Authors:  Carmen Mannucci; Michele Navarra; Fabrizio Calapai; Raffaele Squeri; Sebastiano Gangemi; Gioacchino Calapai
Journal:  Phytother Res       Date:  2016-10-17       Impact factor: 5.878

3.  Fluocinolone acetonide topical oil for scalp psoriasis.

Authors:  M Pauporte; H Maibach; N Lowe; M Pugliese; D J Friedman; H Mendelsohn; I Cargill; R Ramirez
Journal:  J Dermatolog Treat       Date:  2004-12       Impact factor: 3.359

4.  Controlled delivery of testosterone from smart polymer solution based systems: in vitro evaluation.

Authors:  Sibao Chen; Jagdish Singh
Journal:  Int J Pharm       Date:  2005-05-13       Impact factor: 5.875

5.  Development and Evaluation of Topical Delivery of Microemulsions Containing Adapalene (MEs-Ap) for Acne.

Authors:  Bing Shao; Lixin Sun; Na Xu; Hongwei Gu; Hongyu Ji; Linhua Wu
Journal:  AAPS PharmSciTech       Date:  2021-04-06       Impact factor: 3.246

Review 6.  The attentive focus on T cell-mediated autoimmune pathogenesis of psoriasis, lichen planus and vitiligo.

Authors:  Azin Aghamajidi; Ehsan Raoufi; Gilda Parsamanesh; Ahmad Jalili; Mohammad Salehi-Shadkami; Marjan Mehrali; Monireh Mohsenzadegan
Journal:  Scand J Immunol       Date:  2020-11-15       Impact factor: 3.487

7.  A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.

Authors:  P C M van de Kerkhof; V Hoffmann; A Anstey; L Barnes; C Bolduc; K Reich; S Saari; S Segaert; L Vaillant
Journal:  Br J Dermatol       Date:  2008-11-25       Impact factor: 9.302

8.  Transdermal delivery of hydrocortisone from eucalyptus oil microemulsion: effects of cosurfactants.

Authors:  Gamal M El Maghraby
Journal:  Int J Pharm       Date:  2007-12-24       Impact factor: 5.875

Review 9.  Laser assisted drug delivery: a review of an evolving technology.

Authors:  Lindsay R Sklar; Christopher T Burnett; Jill S Waibel; Ronald L Moy; David M Ozog
Journal:  Lasers Surg Med       Date:  2014-03-24       Impact factor: 4.025

Review 10.  Update on psoriasis: A review.

Authors:  Jagadish P Rajguru; Deepthi Maya; Dinesh Kumar; Prerna Suri; Shweta Bhardwaj; Nishitkumar D Patel
Journal:  J Family Med Prim Care       Date:  2020-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.